AWCI
ARIA

Alpine Woods Capital Investors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Alpine Woods Capital Investors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-12,500
Closed -$230K – 434
2013
Q3 		$230K Hold
12,500
– – 0.01% 325
2013
Q2 		$219K Buy
+12,500
New +$222K 0.01% 317

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Alpine Woods Capital Investors's ARIA Position: Q4 2013 in Review

Alpine Woods Capital Investors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2013, closing a stake of 12,500 shares — an estimated $230K sold.

Alpine Woods Capital Investors first reported a position in ARIA in Q2 2013 and held it in 2 quarters. The position peaked at $230K in Q3 2013. 166 funds tracked by Wall St. Rank hold ARIA as of Q4 2013.

  • Alpine Woods Capital Investors reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Alpine Woods Capital Investors sold 12,500 Ariad Pharmaceuticals Inc shares in Q4 2013, an estimated $230K.
  • Alpine Woods Capital Investors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Alpine Woods Capital Investors's Ariad Pharmaceuticals Inc position peaked at $230K in Q3 2013.
  • 166 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2013.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2013, filed 11 Feb 2014.